Rxcurve
HCPCS J8610 · per 2.5 MG

Methotrexate oral 2.5 mg

Products billed under this code include Methotrexate, Trexall.

Payment limit per 2.5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J8610

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Methotrexate Hikma Pharmaceuticals USA Inc. 00054-4550-25 100 $15.70
Methotrexate Hikma Pharmaceuticals USA Inc. 00054-8550-25 100 $15.70
Methotrexate Mylan Pharmaceuticals Inc. 00378-0014-01 100 $15.70
Methotrexate Barr Pharmaceuticals, Inc. 00555-0572-02 100 $15.70
Methotrexate Barr Pharmaceuticals, Inc. 00555-0572-35 36 $5.652
Methotrexate Major Pharmaceuticals 00904-7141-10 20 $3.14
Methotrexate Accord Healthcare Inc 16729-0486-01 100 $15.70
Methotrexate Sun Pharmaceutical Global FZE. 47335-0235-83 100 $15.70
Methotrexate Sun Pharmaceutical Global FZE. 47335-0235-96 36 $5.652
Methotrexate A-S Medication Solutions 50090-3418-09 36 $5.652
Show all 20 products
ProductLabelerNDCUnits / pkgLimit / pkg
Methotrexate A-S Medication Solutions 50090-5457-02 100 $15.70
Methotrexate A-S Medication Solutions 50090-5457-09 36 $5.652
Methotrexate AvPAK 50268-0527-15 50 $7.85
Methotrexate Mylan Institutional Inc. 51079-0670-05 20 $3.14
Methotrexate Aurobindo Pharma USA, Inc. 59651-0182-01 100 $15.70
Methotrexate Chartwell 62135-0772-35 36 $5.652
Trexall Teva Women's Health LLC 51285-0366-01 60 $9.42
Trexall Teva Women's Health LLC 51285-0367-01 90 $14.13
Trexall Teva Women's Health LLC 51285-0368-01 120 $18.84
Trexall Teva Women's Health LLC 51285-0369-01 180 $28.26

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.157 +$0.003 2.5 MG Methotrexate oral 2.5 mg v1, posted September 17, 2026
3Q26 $0.154 +$0.014 2.5 MG Methotrexate oral 2.5 mg v1, posted September 15, 2026
2Q26 $0.14 −$0.011 2.5 MG Methotrexate oral 2.5 mg v1, posted September 15, 2026
1Q26 $0.151 −$0.038 2.5 MG Methotrexate oral 2.5 mg v1, posted September 15, 2026
4Q25 $0.189 −$0.009 2.5 MG Methotrexate oral 2.5 mg v1, posted September 8, 2026
3Q25 $0.198 −$0.003 2.5 MG Methotrexate oral 2.5 mg v1, posted March 10, 2026
2Q25 $0.201 +$0.024 2.5 MG Methotrexate oral 2.5 mg v1, posted March 10, 2026
1Q25 $0.177 −$0.047 2.5 MG Methotrexate oral 2.5 mg v1, posted December 19, 2025
4Q24 $0.224 −$0.015 2.5 MG Methotrexate oral 2.5 mg v1, posted June 11, 2025
3Q24 $0.239 −$0.004 2.5 MG Methotrexate oral 2.5 mg v1, posted June 11, 2025
2Q24 $0.243 −$0.024 2.5 MG Methotrexate oral 2.5 mg v1, posted March 11, 2025
1Q24 $0.267 +$0.012 2.5 MG Methotrexate oral 2.5 mg v1, posted December 19, 2024
4Q23 $0.255 +$0.023 2.5 MG Methotrexate oral 2.5 mg v1, posted October 10, 2024
3Q23 $0.232 −$0.163 2.5 MG Methotrexate oral 2.5 mg v1, posted June 5, 2024
2Q23 $0.395 +$0.169 2.5 MG Methotrexate oral 2.5 mg v1, posted February 23, 2024
1Q23 $0.226 −$0.016 2.5 MG Methotrexate oral 2.5 mg v1, posted December 6, 2023
4Q22 $0.242 +$0.055 2.5 MG Methotrexate oral 2.5 mg v1, posted June 22, 2023
3Q22 $0.187 −$0.028 2.5 MG Methotrexate oral 2.5 mg v1, posted June 9, 2023
2Q22 $0.215 +$0.019 2.5 MG Methotrexate oral 2.5 mg v1, posted December 14, 2022
1Q22 $0.196 −$0.219 2.5 MG Methotrexate oral 2.5 mg v1, posted June 8, 2022
4Q21 $0.415 +$0.042 2.5 MG Methotrexate oral 2.5 mg v1, posted June 2, 2022
3Q21 $0.373 +$0.151 2.5 MG Methotrexate oral 2.5 mg v1, posted June 2, 2022
2Q21 $0.222 +$0.08 2.5 MG Methotrexate oral 2.5 mg v1, posted March 1, 2022
1Q21 $0.142 – 2.5 MG Methotrexate oral 2.5 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files